RevenueThe total money the company brought in from sales, before subtracting any costs.
$33Mβ² +71.0% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
62.8%βΌ β20.7% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isnβt profitable yet.
$2Mβ² +54.4% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
β$56KβΌ β104.4% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing ownerβs slice.
58.6Mβ² +8.4% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$8MβΌ β$113K YoY
StockOtter Β· stockotter.space
About HEALTH IN TECH INC-CLASS A
Health In Tech, Inc. operates as a cutting-edge insurance technology provider. The company delivers a range of specialized insurance solutions for smaller enterprises, such as value-based pricing strategies, group insurance captives, localized community health plans, and collective association health programs. Additionally, it offers the enhanced "do it yourself" benefit system (eDIYBS), a cloud-based SaaS platform engineered to efficiently generate health insurance quotes for small to medium-sized businesses. Health In Tech further supports healthcare administration with its "health intelligence" (HI) card, which streamlines the management of medical records and claims. Complementing this is the HI performance network, an extensive series of medical facilities that utilize Medicare-based reimbursement pricing. This organization was established in 2014 and its principal offices are located in Stuart, Florida.
π¦¦
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)